Prevalence of chronic kidney disease in population-based studies: systematic review.

Zhang QL, Rothenbacher D. · 2008

Read Prevalence of chronic kidney disease in population-based studies: systematic review. by Zhang QL, Rothenbacher D. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2377260.txt.

Introduction

Zhang and Rothenbacher reviewed how common chronic kidney disease is worldwide in 2008. Chronic kidney disease means lasting kidney damage or weak filtering, and it raises the risk of kidney failure and heart disease. Counts depend heavily on which formula doctors use to estimate filtering from a blood test.

They gathered 26 population studies using one standard definition, with samples from 237 to 65,181 people. The median rate was 7.2% among adults aged 30 and over. Among people aged 64 and older, rates ran far higher, from 23.4% to 35.8% across studies. The newer MDRD formula had become the favourite tool over the older Cockcroft-Gault method. The authors warned that detection stays weak in older people, women, and some ethnic groups.

Catalog record

CREATORZhang QL, Rothenbacher D.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2377260

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Prevalence of chronic kidney disease in population-based studies: Systematic review By Qiu-Li Zhang, Dietrich Rothenbacher Published in: BMC Public Health DOI: 10.1186/1471-2458-8-117 ABSTRACT Abstract Background Chronic kidney disease (CKD) is becoming a major public health problem worldwide. This article reviews the published evidence of prevalence of CKD in population-based study samples that used the standardized definition from the Kidney Disease Outcomes Quality Initiative of the National Kidney Foundation (K/DOQI) practice guideline, and particularly focus on performance of serum-creatinine based equations for GFR estimation. We provide a summary of available data about the burden of CKD in various populations. Methods We performed a systematic review of available published data in MEDLINE. A combination of various keywords relevant to CKD was used in this research. Related data of included studies were extracted in a systematic way. Results A total of 26 studies were included in this review. The studies were conducted in different populations, and the number of study participants ranged from 237 to 65181. The median prevalence of CKD was 7.2% in persons aged 30 years or older. In persons aged 64 years or older prevalence of CKD varied from 23.4% to 35.8%. Importantly, the prevalence of CKD strongly depended on which estimating equations were used. The Modification of Diet in Renal Disease Study (MDRD) equation was likely to be preferred in recent epidemiological studies compared to the adjusted Cockcroft-Gault (CG) equation. Conclusion Worldwide, CKD is becoming a common disease in the general population. Accurately detecting CKD in special groups remains inadequate, particularly among elderly persons, females or other ethnic groups such as Asians. BACKGROUND Chronic kidney disease (CKD) is becoming a major public health problem worldwide. The current burden of disease might due to a change of the underlying pathogenicity of CKD. Glomerulonephritis was the one of the leading causes of kidney disease several decades ago. Nowadays, infections have become a less important cause for kidney disease, at least in the western world [1]. Moreover, current evidence suggests that hypertension and diabetes are the two major causes of kidney disease worldwide [2,3]. Given the pathogenic progression of kidney disease, patients with CKD are at high risk for progression to the end stage renal disease (ESRD) – a condition requiring dialysis or kidney transplantation to maintain patients' long-term survival. In 2001, the average annual cost for maintenance of ESRD therapy was between US $70 and $75 billion worldwide excluding kidney transplantation, and the predicted number of ESRD patients will reach over 2 million in 2010 [4]. The enormous costs of treatment lead to a large burden for the health care systems, particularly in developing countries. In addition, CKD has a complicated interrelationship with other diseases [5]. Recent studies have reported that CKD is an independent risk factor for cardiovascular disease (CVD) [6]. Therefore, kidney dysfunction should be an additional target for intervention and prevention of CVD [7]. In 2003, the American Heart Association (AHA) stated that persons with CKD should be regarded as the highest risk group for subsequent CVD [8]. Due to the asymptomatic nature of this disease, CKD is not frequently detected until its later progress, resulting in lost opportunities for prevention. Progress to kidney failure or other adverse outcomes could be prevented or delayed through early detection and treatment of CKD [9,10]. Currently, large efforts have been made to a better detection of progressive kidney disease. In 2002 the Kidney Disease Outcomes Quality Initiative (K/DOQI) of the National Kidney Foundation (NKF) developed a practice guideline for CKD [11]. According to this guideline, CKD is defined as either kidney damage or glomerular filtration rate (GFR) below 60 ml/min/1.73 m2 for three or more months with or without evidence of kidney damage, irrespective of the cause [12]. GFR is estimated by serum creatinine based on equations rather than on direct measurements. Several equations have been developed and the most frequently used ones are the Cockcroft-Gault (CG) equation and the Modification of Diet in Renal Disease Study (MDRD) equation. Both equations are currently considered to be the best methods to estimate GFR for adults in epidemiologic studies [13-15]. A number of epidemiologic studies assessed the prevalence of CKD in different populations and used different equations to estimate kidney function. This article reviews the recently published data on the prevalence of CKD in population-based study samples that used the standardized definition from K/DOQI practice guideline, particularly focuses on performance of estimating equations for GFR such as the MDRD equation and the CG equation, and provides a summary for the burden of CKD. METHODS Search strategy A systematic literature search was conducted in the MEDLINE database (US National Library of Medicine, Bethesda, Maryland) to identify all potentially relevant publications before July 2006. The following words were used for this search: "chronic kidney (or renal) disease", "kidney (or renal) disease", "kidney (or renal) dysfunction", "decreased kidney (renal) function", "glomerular filtration rate", "Cockcroft-Gault equation", "MDRD equation", "prevalence", and "population" or "community". Reference lists of primary original studies and review articles were also checked whether any further related articles could be found (cross-references). Study selection Inclusion criteria were designed to find studies that reported the prevalence of CKD in the general population. Studies were included when carried out in a representative sample of the general population, and when the definition of CKD was based on the K/DOQI practice guideline. We excluded studies with a sample size of less than 50 participants, studies without GFR estimation by serum creatinine-based equations, and studies that provided only serum creatinine concentration. Information published only in abstract form was not included, as the abstracts usually do not provide all necessary information to evaluate the quality of a study. Definition of chronic kidney disease We used the definition of CKD from the K/DOQI practice guideline that was published in 2002 by the National Kidney Foundation (NKF). CKD was defined as CrCl or GFR less than 60 ml/min/1.73 m2 [11,12]. Although CrCl is different from GFR, it is commonly used as an estimation value in practice after adjusting for body surface area (BSA); therefore, we also used CrCl to assess the outcome, and compared CrCl with GFR. The two equations were defined in the following way: Simplified MDRD equation [15,16]: GFR (ml/min/1.73 m2) = 186.3 * (serum creatinine)-1.154 * (age)-0.203 * (0.742 if female) * (1.21 if African American). CG/BSA equation [14]: Creatinine Clearance (ml/min) = (140 – age)/(serum creatinine) * (weight/72) * (0.85 if female), which is further standardized for body surface area (BSA) according to the Dubois and Dubois formula [17]: BSA (m2) = 0.20247 * height (m) 0.725 * weight (kg) 0.425. Creatinine Clearance is also expressed as ml/min/1.73 m2. Serum creatinine is measured in mg/dl, age in years, weight in kg, and GFR is expressed as ml/min/1.73 m2. Data extraction Two investigators reviewed each paper independently. Discrepancies were discussed and agreement was achieved by consensus. When possible, the prevalence of CKD was extracted as an overall value and stratified by estimating equations, by age categories and by gender. In some included studies, the prevalence of CKD was not directly stated but available from published figures or calculated from other available information of the articles. We presented the prevalence of CKD based on GFR estimation only, although both GFR estimation

Read the complete text